Diagnostics
Both companies are noted for growth through acquisition, and 2017 has been a very big year for LabCorp.
The military reviewed bids from 31 suitors and is good to Dec. 20, 2022.
Many people will be surprised to learn that Theranos is still open and doing business, let alone to be able to acquire a $100M loan.
The round was led by Berkshire Partners and TPG Growth, with participation from its co-founders and management team, as well as original investors Oak Investment Partners and J.H. Whitney.
Biotechs are taking notice as a new pool of funding is being made available by venture capital Andreesen Horowitz.
Four months after Jeff Huber stepped down as CEO of GRAIL, the company has tapped his replacement.
Kangmei will supply the JV with 95% of the $7.6M in cash, while BGI will contribute the remaining 5% of the JV’s value with instruments and technology.
This could be the first step in a long journey that could amount to huge profitability for the iPhone maker.
Boston Business Journal pulled together a list of the 25 biggest gainers in the state for 2017, and five of them are biopharma companies.
In the wake of sexual harassment allegations, OrbiMed Advisors’ founder and managing partner Sam Isaly has stepped down from his position.
PRESS RELEASES